Enimera Regs+
Logo Logo Logo Logo
Enimera Regs+
  • Home
  • About
    • About Enimera Regs+
    • Careers
    • Gallery
  • Services
    • Our Services Overview
    • Pharmacovigilance
    • Literature Reviews
    • TGA New Substance Applications (Listed Medicines) and Listed-Assessed Medicines
    • TGA Appeals
    • Medicinal Cannabis
  • GMP LCC Hub
  • Learn
  • Blog
  • Testimonials
  • Resources
  • Contact
  • Home
  • About
    • About Enimera Regs+
    • Careers
    • Gallery
  • Services
    • Our Services Overview
    • Pharmacovigilance
    • Literature Reviews
    • TGA New Substance Applications (Listed Medicines) and Listed-Assessed Medicines
    • TGA Appeals
    • Medicinal Cannabis
  • GMP LCC Hub
  • Learn
  • Blog
  • Testimonials
  • Resources
  • Contact
FDA Shutdown 2025: Impact on Biotech & Pharma Submissions | Enimera RegsPlus
October 13, 2025

The Impact of the 2025 U.S Government Shutdown on FDA Activities: What Biotech and Pharma Need to Know

The U.S. government shutdown that began on October 1, 2025, has created uncertainty across multiple sectors — and the biopharmaceutical

header image of medicine bottle with pills floating out the top
October 17, 2024

Navigating TGA Pathways for Prescription Medicines in Australia: A Brief Overview

Successfully registering a new prescription medicine in Australia requires a deep understanding of the Therapeutic Goods Administration (TGA) approval process.

Preparing Regulatory Strategies
April 20, 2021

What I’ve learnt from preparing Regulatory Strategies Part 1 – 3

Part 1 WHAT I’VE LEARNT FROM PREPARING REGULATORY STRATEGIES – BEFORE YOU BEGIN…. So you’ve been asked to prepare a regulatory strategy…

Panel Discussion
October 21, 2020

How has the COVID-19 pandemic impacted Regulatory professionals?

Last week I had the pleasure of chairing a Regulatory Managers panel discussion where we discussed this topic. How many of

Biologicals
August 29, 2020

BiologicALs vs Biologics – two letters to FMT

Australia’s Therapeutic Goods Administration (TGA) announced earlier this year that Faecal Microbiota Transplant (FMT) would be regulated as biologicALs. Yet,

Online learning in Regulatory Affairs
August 27, 2020

Introducing new online learning in Regulatory Affairs

Introducing a very different type of on-line learning in Regulatory Affairs. Flexible and engaging, tutorial access over six or nine months,

Recent Posts

  • The Impact of the 2025 U.S Government Shutdown on FDA Activities: What Biotech and Pharma Need to Know
  • Navigating TGA Pathways for Prescription Medicines in Australia: A Brief Overview
  • What I’ve learnt from preparing Regulatory Strategies Part 1 – 3
  • How has the COVID-19 pandemic impacted Regulatory professionals?
  • BiologicALs vs Biologics – two letters to FMT

Categories

  • Blog
  • Mentoring
  • Online learning
  • Productivity and Effectiveness
  • Regulatory
  • Strategic and Operational Regulatory
  • Translational Research

Tags

#FDApharmaceuticals #shutdownbiotech Biologic Biological Education enimeraregs+ FDA FDA Regulatory Strategy medical device regulatory consulting Medicinal Cannabis Online learning Regulatory Affairs Regulatory Support Strategy TGA TGA Regulatory Matters USGovernmentshutdown

a© Enimera RegPlus Pty Ltd